Protagonist Logo. Click to navigate to a home page

Oxford Global’s 4th Annual Peptide Congress

April 24-25, 2017 12:00 PM ET

London, UK, Novotel London West United States


Session: Advances in Peptide Therapeutics
Presentation:
 Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, in Clinical Development for the Treatment of Inflammatory Bowel Disease
Presenter:
 Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics
Date and Time:
 9-9:30 AM BST, Tuesday April 25
Room:
 Conference Room 3- Epernay

Share by: